Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H van Den Hoogen

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
British Journal of Rheumatology|December 1, 1994
Long-term follow-up of 46 patients with anti-(U1)snRNP antibodiesF H van den Hoogen, P E Spronk, A M Boerbooms, et al.
Annals of the Rheumatic Diseases|April 17, 2001
Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjögren's syndromeM M Zandbelt, F H van den Hoogen, P C de Wilde, et al.
Journal of Leukocyte Biology|May 15, 1998
Expression of macrophage-derived chemokine (MDC) mRNA in macrophages is enhanced by interleukin-1beta, tumor necrosis factor alpha, and lipopolysaccharideR J Rodenburg, R F Brinkhuis, R Peek, et al.
Acta Dermato-Venereologica|October 21, 1998
Decreased staining of heparan sulfate in non-lesional skin of a subgroup of patients with systemic lupus erythematosusM M Seyger, M C van Bruggen, H K Hardeman, et al.
Annals of the Rheumatic Diseases|October 1, 1993
Effects of methotrexate on glycosaminoglycan production by scleroderma fibroblasts in cultureF H van den Hoogen, P M van der Kraan, A M Boerbooms, et al.
Annals of the Rheumatic Diseases|September 11, 2008
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosisC P Denton, M Engelhart, N Tvede, et al.
The Netherlands Journal of Medicine|April 1, 1991
Diagnostic and prognostic value of quantitative immunohistological examination of lip biopsy in Sjögren's syndromeC Bodeutsch, P C de Wilde, L Kater, et al.
Journal of Clinical Pathology|February 1, 1993
Monotypic plasma cells in labial salivary glands of patients with Sjögren's syndrome: prognosticator for systemic lymphoproliferative diseaseC Bodeutsch, P C de Wilde, L Kater, et al.
Pathology, Research and Practice|June 1, 1992
Quantitative immunohistologic study of lip biopsies. Evaluation of diagnostic and prognostic value in Sjögren's syndromeC Bodeutsch, P C de Wilde, L Kater, et al.
Experimental and Clinical Immunogenetics|August 6, 1998
Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosisG T Venneker, F H van den Hoogen, M van Meegen, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
British Journal of Rheumatology|December 1, 1994
Long-term follow-up of 46 patients with anti-(U1)snRNP antibodiesF H van den Hoogen, P E Spronk, A M Boerbooms, et al.
Annals of the Rheumatic Diseases|April 17, 2001
Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjögren's syndromeM M Zandbelt, F H van den Hoogen, P C de Wilde, et al.
Journal of Leukocyte Biology|May 15, 1998
Expression of macrophage-derived chemokine (MDC) mRNA in macrophages is enhanced by interleukin-1beta, tumor necrosis factor alpha, and lipopolysaccharideR J Rodenburg, R F Brinkhuis, R Peek, et al.
Acta Dermato-Venereologica|October 21, 1998
Decreased staining of heparan sulfate in non-lesional skin of a subgroup of patients with systemic lupus erythematosusM M Seyger, M C van Bruggen, H K Hardeman, et al.
Annals of the Rheumatic Diseases|October 1, 1993
Effects of methotrexate on glycosaminoglycan production by scleroderma fibroblasts in cultureF H van den Hoogen, P M van der Kraan, A M Boerbooms, et al.
Annals of the Rheumatic Diseases|September 11, 2008
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosisC P Denton, M Engelhart, N Tvede, et al.
The Netherlands Journal of Medicine|April 1, 1991
Diagnostic and prognostic value of quantitative immunohistological examination of lip biopsy in Sjögren's syndromeC Bodeutsch, P C de Wilde, L Kater, et al.
Journal of Clinical Pathology|February 1, 1993
Monotypic plasma cells in labial salivary glands of patients with Sjögren's syndrome: prognosticator for systemic lymphoproliferative diseaseC Bodeutsch, P C de Wilde, L Kater, et al.
Pathology, Research and Practice|June 1, 1992
Quantitative immunohistologic study of lip biopsies. Evaluation of diagnostic and prognostic value in Sjögren's syndromeC Bodeutsch, P C de Wilde, L Kater, et al.
Experimental and Clinical Immunogenetics|August 6, 1998
Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosisG T Venneker, F H van den Hoogen, M van Meegen, et al.
Pageof 5